Abnormalities in brain serotonin concentration, high-affinity uptake, and tryptophan hydroxylase activity in severe-seizure genetically epilepsy-prone rats

Epilepsia

Volumn 37, Issue 4, 1996, Pages 311-321

  Statnick, Michael A ^a   Dailey, John W ^b   Jobe, Philip C ^b   Browning, Ronald A ^a  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ILLINOIS   (United States)

Author keywords

Audiogenic seizures; Epilepsy; Genetically epilepsy prone rats; Presynaptic markers; Serotonin; Synaptosomes; Tryptophan hydroxylase

Indexed keywords

SEROTONIN; TRYPTOPHAN HYDROXYLASE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; EPILEPSY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SEROTONIN BRAIN LEVEL; SEROTONIN UPTAKE; SEROTONINERGIC NERVE CELL; SYNAPTOSOME; TRANSPORT KINETICS;

ACOUSTIC STIMULATION; ANIMALS; BIOLOGICAL MARKERS; BRAIN; DISEASE MODELS, ANIMAL; EPILEPSY; MALE; PRESYNAPTIC TERMINALS; RATS; SEIZURES; SEROTONIN; SYNAPTOSOMES; TISSUE DISTRIBUTION; TRYPTOPHAN HYDROXYLASE;

EID: 0029876438     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1528-1157.1996.tb00565.x     Document Type: Article

References (50)

1. Buterbaugh GG. Effect of drugs modifying central serotonergic function of the response of extensor and nonextensor rats to maximal electroshock. Life Sci 1978;23:2393-404.
2. Browning RA, Hoffman WE, Simonton RL. Changes in seizure susceptibility after intracerebral treatment with 5,7-dihydroxytryptamine: role of serotonergic neurons. Ann NY Acad Sci 1978;305:437-56.
3. Loscher W, Czuczwar SJ. Evaluation on the 5-hydroxytryptamine receptor agonist 8-hydroxy-2-(di-n-propyl-amino)tetralin in different rodent models of epilepsy. Neurosci Lett 1985;60:201-6.
4. Buus Lassen J. Potent and long-lasting potentiation of two 5-hydroxytryptophan-induced effects in mice by three selective 5-HT uptake inhibitors. Eur J Pharmacol 1978;47:351-8.
5. Kovacs DA, Zoll JG. Seizure inhibition by median raphe nucleus stimulation in rat. Brain Res 1974;70:165-9.
6. Lazarova M, Bendotti C, Samanin R. Studies on the role of serotonin in different regions of the rat central nervous system on pentylenetetrazol-induced seizures and the effect of di-n-propylacetate. Naunyn Schmiedebergs Arch Pharmacol 1983;322:147-52.
7. Lazarova M, Bendotti C, Samanin R. Evidence that the dorsal raphe area is involved in the effect of clonidine against pentylenetetrazol-induced seizures in rats. Naunyn Schmiedebergs Arch Pharmacol 1984;325:12-6.
8. Racine R, Coscina DV. Effects of midbrain raphe lesions or systemic p-chlorophenylalanine on the development of kindled seizures in rats. Brain Res Bull 1979;4:1-7.
9. Wada Y, Nakamura M, Hasegawa H, Yamaguchi N. Role of serotonin receptor subtype in seizures kindled from the feline hippocampus. Neurosci Lett 1992;141:21-4.
10. Wada Y, Nakamura M, Hasegawa H, Yamaguchi N. Effect of serotonin uptake inhibiting antidepressants on hippocampal kindled seizures in cats. Neurosci Res Commun 1993;12: 119-24.
11. Meldrum BS, Balzamo E, Wada JA, Vuillon-Cacciuttolo G. Effects of L-tryptophan, L-3,4-dihydroxyphenylalanine and tranylcypromine on the electroencephalogram and on photically induced epilepsy in the baboon, Papio papio. Physiol Behav 1972;9:615-21.
12. Wada JA, Balzamo E, Meldrum BS, Naquet R. Behavioral and electrographic effects of L-5-hydroxytryptophan and D,L-parachlorophenylalanine on epileptic Senegalese baboon (Papio papio). Electroencephalogr Clin Neurophysiol 1972;33:520-6.
13. Jobe PC, Picchioni AL, Chin L. Role of brain 5-hydroxytryptamine in audiogenic seizure in the rat. Life Sci 1973;13: 1-13.
14. Prendiville S, Gale K. Anticonvulsant effect of fluoxetine on focally evoked limbic motor seizures in rats. Epilepsia 1993; 34:381-4.
15. Pasini A, Tortorell A, Gale K. Anticonvulsant effect of intranigral fluoxetine. Brain Res 1992;593:287-90.
16. Laird II HE, Jobe PC. The genetically epilepsy-prone rat. In: Jobe PC, Laird II HE, eds. Neurotransmitters and epilepsy. Clifton, NJ: Humana Press, 1987:57-94.
17. Reigel CE, Dailey JW, Jobe PC. The genetically epilepsy-prone rat: an overview of seizure-prone characteristics and responsiveness to anticonvulsant drugs. Life Sci 1986;39: 763-74.
18. Dailey JW, Reigel CE, Mishra PK, Jobe C. Neurobiology of seizure predisposition in the genetically epilepsy-prone rat. Epilepsy Res 1989;3:3-17.
19. Millan MH, Wardley-Smith B, Durmuller N, Meldrum BS. The high pressure neurological syndrome in genetically epilepsy-prone rats: protective effect of 2-amino-7-phosphonoheptanoate. Exp Neurol 1991;112:317-20.
20. Jobe PC, Dailey JW, Reigel CE. Noradrenergic and serotonergic determinants of seizure susceptibility and severity in genetically epilepsy-prone rats. Life Sci 1986;39:775-82.
21. Dailey JW, Mishra PK, Ko KH, Penny JE, Jobe PC. Serotonergic abnormalities in the central nervous system of seizure-naive genetically epilepsy-prone rats. Life Sci 1992;50: 319-26.
22. Dailey JW, Yan QS, Mishra PK, Burger RL, Jobe PC. Effects of fluoxetine on convulsions and on brain serotonin as detected by microdialysis in genetically epilepsy-prone rats. J Pharmacol Exp Ther 1992;260:533-40.
23. Statnick MA, Wang C, Maring ML, Dailey JW, Jobe PC, Browning RA. Effect of 5,7-dihydroxytryptamine (5,7-DHT) on audiogenic seizures in genetically epilepsy-prone rats. Soc Neurosci Abstr 1992;18:907.
24. Jobe PC, Picchioni AL, Chin L. Role of brain norepinephrine in audiogenic seizure in the rat. J Pharmacol Exp Ther 1973;184:1-10.
25. Mefford IN. Application of high performance liquid chromatography with electrochemical analysis: measurement of catecholamines, serotonin and metabolites in rat brain. J Neurosci Methods 1981;2:207-24.
26. Gray EG, Whittaker VP. The isolation of nerve endings from brain: an electron-microscopic study of cell fragments derived by homogenization and centrifugation. J Anat 1962; 193:79-88.
27. Marquardt DW. An algorithm for least squares estimation of nonlinear parameters. J Soc Indust Appl Math 1963;2:431-41.
28. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-54.
29. Carlsson A, Davis JN, Kehr W, Lindquist M, Atack CV. Simultaneous measurement of tyrosine and tryptophan hydroxylase activities in brain in vivo using an inhibitor of aromatic amino acid decarboxylase. Naunyn Schmiedebergs Arch Pharmacol 1971;275:153-68.
30. Boadle-Biber MC, Johannessen JN, Narasimhachari N, Phan TH. Tryptophan hydroxylase: increase in activity by electrical stimulation of serotonergic neurons. Neurochem Int 1986;8:83-92.
31. Browning RA, Wade DR, Marcinczyk M, Long GL, Jobe PC. Regional brain abnormalities in norepinephrine uptake and dopamine-β-hydroxylase activity in the genetically epilepsy-prone rat. J Pharmacol Exp Ther 1989;249:229-35.
32. Lebrecht U, Nowak JZ. Effect of single and repeated electroconvulsive shock on serotonergic system in rat brain - I: metabolic studies. Neuropharmacology 1980;19:1049-53.
33. Minchin MCW, Williams J, Bowdler JM, Green AR. Effect of electroconvulsive shock on the uptake and release of noradrenaline and 5-hydroxytryptamine in rat brain slices. J Neurochem 1983;40:765-8.
34. Green AR, Heal DJ, Vincent ND. The effect of single and repeated electroconvulsive shock administration on the release of 5-hydroxytryptamine and noradrenaline from cortical slices of rat brain. Br J Pharmacol 1987;92:25-30.
35. Reigel CE, Joliff JJ, Jobe PC, Mishra PK. Ontogeny of monoaminergic determinants of seizure susceptibility and severity in the genetically epilepsy-prone rat. Neurosci Abstr 1987;13:943.
36. Boadle-Biber MC, Corley KC, Graves L, Phan TH, Rosecrans J. Increase in the activity of tryptophan hydroxylase from cortex and midbrain of male Fisher 344 rats in response to acute or repeated sound stress. Brain Res 1989;482:306-16.
37. Browning RA, Wang C, Jobe PC. Effect of precollicular transection on audiogenic seizures in genetically epilepsy-prone rats (GEPRs). Soc Neurosci Abstr 1991;17:508.
38. Coffey LL, Reith ME, Chen NH, Jobe PC. Brainstem seizures in amygdala-kindled genetically epilepsy-prone rats (GEPRs). Soc Neurosci Abstr 1994;20:1458.
39. Browning RA. Anatomy of generalized convulsive seizures. In. Malafosse A, Genton P, Hirsch E, Marescaux C, Broglin D, Bernasconi R, eds. Idiopathic generalized epilepsies: clinical, experimental, and genetic aspects. London: John Libbey, 1994:339-413.
40. Dailey JW, Jobe PC. Indices of noradrenergic function in the central nervous system of seizure-naive genetically epilepsy-prone rats. Epilepsia 1986;27:665-70.
41. Lauterborn JC, Ribak CE. Differences in dopamine-beta-hydroxylase immunoreactivity between the brains of genetically epilepsy-prone and Sprague-Dawley rats. Epilepsy Res 1989;4:161-76.
42. Verma AK, Gupta SK, Maheshwari MC. 5-HIAA in cerebrospinal fluid of patients with status epilepticus. Epilepsia 1984;25:499-501.
43. Garelis E, Sourkes TL. Use of cerebrospinal fluid drawn at pneumoencephalography in the study of monoamine metabolism in man. J Neurol Neurosurg Psychiatry 1974;37:704-10.
44. Shaywitz BA, Cohen DJ, Bowers MB. Reduced cerebrospinal fluid 5-hydroxyindoleacetic acid and homovanillic acid in children with epilepsy. Neurology 1975;25:72-9.
45. Giroud M, Dumas R, Dauvergne M, et al. 5-Hydroxyindole-acetic acid and homovanillic acid in cerebrospinal fluid of children with febrile convulsions. Epilepsia 1990;31:178-81.
46. Chadwick DP, Jenner P, Reynolds EH. Amines, anticonvulsants and epilepsy. Lancet 1975;1:474-6.
47. Leino E, MacDonald E, Airaksinen MM, Riekkinen P, Salo H. L-Tryptophan-carbidopa trial in patients with longstanding progressive myoclonus epilepsy. Acta Neurol Scand 1981;64:132-41.
48. Snead III CO. On the sacred disease: The neurochemistry of epilepsy. Int Rev Neurobiol 1983;24:94-179.
49. Pranzatelli MR. Serotonin and human myoclonus: rationale for use of serotonin receptor agonists and antagonists. Arch Neurol 1994;51:605-17.
50. Pranzatelli MR, Tate E, Huang Y, et al. Neuropharmacology of progressive myoclonus epilepsy: response to 5-hydroxy-L-tryptophan. Epilepsia 1995;36:783-91.